Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population
文献类型：期刊论文
| 刊名 | JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B
 |
| 出版日期 | 2013 |
| 卷号 | 14 |
| 关键词 | COLORECTAL-CANCER GENE POLYMORPHISMS CLINICAL-RESPONSE PLUS CARBOPLATIN REPAIR GENES SURVIVAL ERCC1 ASSOCIATION PLATINUM FOLATE Non-small cell lung cancer Single nucleotide polymorphism Methylenetetrahydrofolate reductase Gemcitabine Excision repair cross-complementation group 1 |
| ISSN号 | 1673-1581 |
| 其他题名 | Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population * |
| 英文摘要 | The aim of this study was to evaluate the association between the methylenetetrahydrofolate reductase (MTHFR) C677T excision repair cross-complementation group 1 (ERCC1) genetic polymorphisms and the clinical efficacy of gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC). |
| 资助项目 | [National Natural Science Foundation of China] ; [Medical Scientific Research Foundation of Zhejiang Province] ; [Science and Technology Department of Zhejiang Province] ; [Zhejiang Major Science and Technology Special Project, China] |
| 语种 | 英语 |
| CSCD记录号 | CSCD:4784516 |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/49211]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 推荐引用方式 GB/T 7714 | . Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population[J]. JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B,2013,14. |
| APA | (2013).Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population.JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B,14. |
| MLA | "Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population".JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B 14(2013). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。